The Covid pandemic drives Pfizer ' s 2022 revenue to a record $100 billion
Empty vials of Pfizer-BioNTech coronavirus disease (COVID-19) children's vaccines are pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., May 19, 2022. The ongoing Covid-19 pandemic propelled pharmaceutical company Pfizer's earnings to a record $100 billion last year, almost $57…#skippackpharmacy #schwenksville #pennsylvania #pfizer #eps #albertbourla #rsv
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Children | Coronavirus | Covid Vaccine | COVID-19 | Health | Pandemics | Pfizer | Vaccines